glp-1 weight loss drug World Health Organization issues first-ever guidelines for use of medications Professor Receives Grant to Study

Ozempic alternatives in the GLP-1 family offer effective weight loss pathways

Full dose or microdose

These medications exert (in)direct hepatic actions by reducing steatosis, attenuating inflammation, and potentially reversing fibrosis, while simultaneously addressing systemic metabolic abnormalities including excessive obesity, insulin resistance, and cardiovascular risk

Eli Lilly GLP-1 pill orforglipron could revolutionize the weight loss world by the end of 2025 after promising Phase 3 trial results.

Supports gut lining integrity

Plus, it primes your body to stay in fat-burning mode, bringing you one step closer to a leaner, sculpted physique